Skip to content

Using mobile app to do self-check of brain function in people with brain tumors.

Self-administered remote NEurological examination using MObile application in patients with brain tumors. - NEMO study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098246
Enrollment
600
Registered
2025-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D496- Neoplasm of unspecified behavior of brain

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of brain tumors (histopathology/ radiology) Age greater than 4 years Patient or caregiver have access to an android smart phone and is able to install the mobile application Expected survival more than 6 months during study accrual Signing patient consent or parent consent/ child assent form (as appropriate)

Exclusion criteria

Exclusion criteria: Patient or caregiver is not reliable to follow instructions or use the mobile application Patient with severe cognitive or psychiatric issues causing difficulty in using the app or follow instructions Karnofsky Performance Status (KPS) or Lansky Performance Status LPS) is less than 50 Terminal illness with expected life expectancy (less than 6 months)

Design outcomes

Primary

MeasureTime frame
Development of a mobile application equipped with symptom assessment and recording videos as patients perform specific neurological tasks Development and validation of the AI model to detect functional changes and predict subsequent neurological deteriorationTimepoint: Development of a mobile application equipped with symptom assessment and recording videos as patients perform specific neurological tasks Development and validation of the AI model to detect functional changes and predict subsequent neurological deterioration in 2 years

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Archya Dasgupta

Tata Memorial Centre, Mumbai

archya1010@gmail.com8097081506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026